Evaluation of proton therapy dose in breast cancer with boron agent based on GATE Monte Carlo code

IF 2.5 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Journal of Radiation Research and Applied Sciences Pub Date : 2025-03-01 Epub Date: 2025-02-02 DOI:10.1016/j.jrras.2025.101311
Fereshteh Mollaee Bijarpasi, Alireza Sadremomtaz
{"title":"Evaluation of proton therapy dose in breast cancer with boron agent based on GATE Monte Carlo code","authors":"Fereshteh Mollaee Bijarpasi,&nbsp;Alireza Sadremomtaz","doi":"10.1016/j.jrras.2025.101311","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Proton Boron Capture Therapy (PBCT) has been introduced as a proposed method of increasing the proton therapy dose. The interaction mechanism of this reaction is p + <sup>11</sup>B → 3α<strong>.</strong> This research was carried out to evaluat<strong>e</strong> the dose of proton beams with boron agents.</div></div><div><h3>Methods</h3><div>All the simulations were done with Monte Carlo GATE code. First, the proton beam and the breast phantom were simulated, and then different boron concentrations were created in the tumor area. Finally, using the dose actor, the amount of the deposited dose, the deposited energy, and the dose of secondary alpha particles in the tumor area were calculated.</div></div><div><h3>Results</h3><div>The simulation results show that at a concentration of 65 ppm of 11B, the dose changes are less than 1% compared to the tumor area without boron, and the depth of the Bragg peak remains unchanged. By increasing the concentration of boron in the tumor area, the deposited dose and the depth of the Bragg peak decrease. In pure <sup>11</sup>B, the deposited dose is reduced to half of the original amount.</div></div><div><h3>Conclusion</h3><div>By placing different concentrations of boron agents, the physical aspects and simulation results did not show that boron is effective in increasing the dose in proton therapy. Therefore, <sup>11</sup>B cannot be used as a dose-enhancing agent in proton therapy.</div></div>","PeriodicalId":16920,"journal":{"name":"Journal of Radiation Research and Applied Sciences","volume":"18 1","pages":"Article 101311"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Radiation Research and Applied Sciences","FirstCategoryId":"103","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1687850725000238","RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Proton Boron Capture Therapy (PBCT) has been introduced as a proposed method of increasing the proton therapy dose. The interaction mechanism of this reaction is p + 11B → 3α. This research was carried out to evaluate the dose of proton beams with boron agents.

Methods

All the simulations were done with Monte Carlo GATE code. First, the proton beam and the breast phantom were simulated, and then different boron concentrations were created in the tumor area. Finally, using the dose actor, the amount of the deposited dose, the deposited energy, and the dose of secondary alpha particles in the tumor area were calculated.

Results

The simulation results show that at a concentration of 65 ppm of 11B, the dose changes are less than 1% compared to the tumor area without boron, and the depth of the Bragg peak remains unchanged. By increasing the concentration of boron in the tumor area, the deposited dose and the depth of the Bragg peak decrease. In pure 11B, the deposited dose is reduced to half of the original amount.

Conclusion

By placing different concentrations of boron agents, the physical aspects and simulation results did not show that boron is effective in increasing the dose in proton therapy. Therefore, 11B cannot be used as a dose-enhancing agent in proton therapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于GATE蒙特卡罗代码的乳腺癌硼剂质子治疗剂量评估
目的质子硼捕获疗法(PBCT)是一种增加质子治疗剂量的方法。该反应的相互作用机制为p + 11B→3α。本研究对含硼剂质子束的剂量进行了评价。方法采用Monte Carlo GATE程序进行仿真。首先,模拟质子束和乳房幻象,然后在肿瘤区域制造不同浓度的硼。最后,利用剂量因子计算沉积剂量、沉积能量和肿瘤区域次级α粒子的剂量。结果模拟结果表明,在11B浓度为65 ppm时,与不含硼的肿瘤区域相比,剂量变化小于1%,Bragg峰深度保持不变。随着肿瘤区域硼浓度的增加,沉积剂量和Bragg峰深度减小。在纯11B中,沉积剂量减少到原始量的一半。结论在质子治疗中,不同浓度硼剂的放置,物理和模拟结果均未显示硼剂对增加剂量的效果。因此,11B不能作为质子治疗的剂量增强剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
5.90%
发文量
130
审稿时长
16 weeks
期刊介绍: Journal of Radiation Research and Applied Sciences provides a high quality medium for the publication of substantial, original and scientific and technological papers on the development and applications of nuclear, radiation and isotopes in biology, medicine, drugs, biochemistry, microbiology, agriculture, entomology, food technology, chemistry, physics, solid states, engineering, environmental and applied sciences.
期刊最新文献
Shugananshen recipe improves insomnia in humans and alleviates anxiety in rats by altering expressions of key signaling molecules Knowledge and awareness of ionizing radiation hazards in diagnostic imaging among patients at King Abdulaziz Medical City, Jeddah, Saudi Arabia The role of AKR1C3 in regulating chondrocyte aging in knee osteoarthritis AI-enhanced analytical and numerical solutions for fractional cancer tumor models in older adults using healthcare technologies Danshou Tang alleviates mitochondrial oxidative stress and modulates apoptosis to improve recurrent spontaneous abortion outcomes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1